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Abstract
Most genes along the male single X chromosome in Drosophila are hypertranscribed about two-fold relative to each of the
two female X chromosomes. This is accomplished by the MSL (male-specific lethal) complex that acetylates histone H4 at
lysine 16. The MSL complex contains two large noncoding RNAs, roX1 (RNA on X) and roX2, that help target chromatin
modifying enzymes to the X. The roX RNAs are functionally redundant but differ in size, sequence, and transcriptional
control. We wanted to find out how roX1 production is regulated. Ectopic DC can be induced in wild-type (roX1
+ roX2
+)
females if we provide a heterologous source of MSL2. However, in the absence of roX2, we found that roX1 expression failed
to come on reliably. Using an in situ hybridization probe that is specific only to endogenous roX1, we found that expression
was restored if we introduced either roX2 or a truncated but functional version of roX1. This shows that pre-existing roX RNA
is required to positively autoregulate roX1 expression. We also observed massive cis spreading of the MSL complex from the
site of roX1 transcription at its endogenous location on the X chromosome. We propose that retention of newly assembled
MSL complex around the roX gene is needed to drive sustained transcription and that spreading into flanking chromatin
contributes to the X chromosome targeting specificity. Finally, we found that the gene encoding the key male-limited
protein subunit, msl2, is transcribed predominantly during DNA replication. This suggests that new MSL complex is made as
the chromatin template doubles. We offer a model describing how the production of roX1 and msl2, two key components of
the MSL complex, are coordinated to meet the dosage compensation demands of the male cell.
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Introduction
Some long noncoding RNAs have the ability to recruit
chromatin modifying enzymes to specific genes thereby controlling
their expression [1]. Other noncoding RNAs behave as transcrip-
tional enhancers to flanking protein coding genes [2]. The two roX
RNAs that participate in dosage compensation of the single male
X chromosome in Drosophila are some of the best characterized
examples of noncoding RNAs that target chromatin remodeling
enzymes to large domains [3]. The roX RNAs assemble into a
complex containing at least five MSL protein subunits that bind
actively transcribed genes along the male X chromosome, but not
autosomes or the two X chromosomes in females [4]. This has
been termed the dosage compensation complex or the MSL
complex. One function of the complex is acetylation of histone H4
at lysine 16, carried out by the MOF (males absent on first) histone
acetyltransferase resulting in an essential ,two-fold increase in
transcription [5–8]. Another modification is ubiquitylation of
histone H2B at K34 by the MSL2 RING finger protein [9].
Flies carry two roX genes that differ greatly in size and sequence
[10]. The roX1 gene is located on the X chromosome at polytene
band 3F and produces a 3.7 kb RNA. The roX2 gene is located at
10C on the X and makes a ,600 nt RNA. Both RNAs ‘paint’ the
length of the male X in a banded pattern [11]. The only obvious
sequence similarity between them is limited to short repeated
elements near the 39 end of each gene [12]. These repeats are
essential for function and predicted to fold into conserved
secondary structures [13,14]. Neither roX RNA is maternally
deposited in eggs. Zygotic transcription of roX1 RNA occurs in
both male and female embryos beginning at blastoderm [15].
Females lose roX1 RNA midway through embryogenesis, but
males maintain expression through adulthood. By contrast, roX2
RNA first appears a few hours after roX1 but only in male embryos
[16]. Despite the vast differences in size, sequence, and regulation,
the two roX RNAs are functionally redundant [17].
Little is known about how production of the roX RNAs and
MSL protein subunits are coordinated. Unusual cis spreading
behavior of MSL complex from sites of autosomal roX transgene
has been attributed to cotranscriptional assembly of free MSL
subunits onto growing nascent roX transcripts [13,18,19], although
direct biochemical evidence is lacking. Most MSL protein subunits
are made in both males and females, except for MSL2 which is
translationally repressed in females by the action of SXL [20,21].
MSL2 is a RING finger protein that binds DNA in a sequence
independent manner through a second cysteine-rich motif [22].
The H83M2 transgene removes the 59 and 39 UTRs containing
SXL binding sites from msl2 mRNA and has been used extensively
to drive ectopic MSL2 expression in females [5,11,15,17,23–29].
Forcing females to make MSL2 using the H83M2 transgene
induces production of roX RNAs, resulting in ectopic dosage
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led to the idea that MSL2 protein alone, or acting with the other
MSL proteins drives transcription of roX1 RNA [31–33].
We reexamined the question of how MSL proteins regulate
transcription of the roX1 gene using flies missing the roX2 locus.
Deleting roX2 allowed us to study expression of the wild type
endogenous roX1 gene without the confounding effects of a second
functionally redundant RNA species. In this way we found an
RNA-dependent autoregulatory loop controlling roX1 expression.
We propose that the early burst of roX1 transcription at
blastoderm initiates this cycle. Furthermore, production of the
key male-limited MSL2 protein subunit is not only regulated at the
translational level as has been extensively documented, but we find
msl2 transcription is associated with DNA replication. We propose
a model where pre-existing roX RNA, assembled in mature MSL
complexes, drives bursts of roX1 transcription during S phase when
its chromatin target is doubling.
Results
roX1 transcription is dependent on roX2 RNA
Male embryos normally establish dosage compensation by the
onset of gastrulation [16,34]. Ectopic expression of MSL2 in
females leads to roX1 transcription and dosage compensation [15].
We asked whether dosage compensation can only be initiated
during early embryogenesis, or could it be artificially started later
during larval development. To achieve that, we used an inducible
Flp-out system [35] to create clones of GAL4 expressing cells on
day 4 AEL (after egg laying) that in turn drove expression of UAS-
GFP and UAS-MSL2 in female larvae (Figure 1A and Methods).
The purpose of this was to assay females in which the early burst of
roX1 RNA had decayed away leaving cells devoid of any roX RNA.
When no clones were induced, we never observed GFP or MSL
painting in any cell showing that expression was tightly blocked
prior to induction (data not shown). Third instar larvae in which
late GAL4+ clones were induced displayed overlapping expression
of GFP and MSL2 (Figure 1B–1B0). More importantly, MSL2
appeared as subnuclear punctate staining in imaginal disc cells
suggesting that it was concentrated on the X chromosome
(Figure 1B0). MSL2 immunostaining of polytene squashes
confirmed binding along the X (Figure 1C). Unfortunately, we
were unable to perform GFP immunostaining and reliable roX1
FISH (Fluorescence in situ hybridization) in the same glands as the
proteinase K treatment necessary to expose roX RNA often
destroyed protein epitopes. We took comparable salivary glands
from GFP positive larvae (Figure 1D) and processed them for roX1
FISH. The results show that roX1 transcription was successfully
induced (Figure 1E–1F), consistent with previous reports that
MSL2 drives roX1 transcription [15], and confirms an earlier
report that dosage compensation can be initiated long after it
normally occurs [13]. Figure 1G shows a wild type male X for
comparison.
We repeated the experiment in roX1
+ roX2
2 females (Figure 1H).
While GFP+ clones were recovered at similar frequencies
indicating successful MSL2 induction (Figure 1I, 1K), no MSL2
accumulation was observed in imaginal discs (Figure 1I9)o ro n
polytene chromosomes (Figure 1J). We will later demonstrate that
the failure to detect MSL2 is due to reduced protein stability in the
absence of roX RNA. More importantly, we also could not detect
roX1 expression in any cell. Absence of roX1 RNA might be
attributed to poor RNA stability or transcription failure. We favor
the latter since even minute amounts of roX1 transcription can be
readily detected when MSL complex accumulates over the roX1
gene [13]. Moreover, we could not detect nascent transcripts from
the roX1 locus in these animals although such nascent roX1
transcripts were easily detected in other genotypes (Figure 1L–1L9,
1M). This argues that although late MSL2 readily switches on
roX2, it is not sufficient alone or with the other MSL subunits to
drive expression of the roX1 gene when roX2 is absent. Without
any roX RNA, cells rapidly destroy the ectopic MSL2 as well.
To further test our hypothesis that late expression of the
endogenous roX1 locus depends on roX2 RNA, we returned to
wildtype (roX1
+ roX2
+) females to perform RNA in situ hybridiza-
tion for both RNAs in the same nuclei. Late induction of MSL2
results in roX2 RNA painting the length of X chromosomes in
many cells (Figure 2A9). By contrast, roX1 painting over the full X
chromosome was seen in only a small minority of nuclei
(Figure 2A). A much more common pattern was roX2 over the
entire X while roX1 expression confined to either several Mbp
(Figure 2B–2B9) around or just at the endogenous roX1 locus at
polytene band 3F (Figure 2C–2C9). This suggests that roX2
expression reliably follows MSL2 induction, but roX1 expression
lags. Delayed roX1 expression might be explained if fully functional
MSL complex containing roX2 RNA must first assemble before
transcription of roX1 can occur. We conclude that roX2 RNA,
presumably packaged in mature MSL complexes, is necessary to
initiate transcription from the endogenous roX1 gene late in
development.
Autoregulation of roX1 expression
Finding unusually late activation of the roX1 gene required
preexisting roX2 RNA, we wondered if roX1 RNA could also
perform the same role leading to a positive autoregulatory loop.
To answer this question, we used a fly stock displaying an unusual
mosaic pattern of dosage compensation.
The H83M2 transgene makes MSL2 constitutively using the
hsp83 promoter [30]. It lacks the regulatory 59 and 39 msl2 UTRs
and drives ectopic dosage compensation in 100% of female cells.
Females carrying a roX1 deletion also showed MSL X chromo-
some painting utilizing roX2 RNA in all nuclei (data not shown).
However, an entirely different result was obtained in H83M2
females missing only roX2. Roughly half the nuclei adopted a fully
male-like pattern of dosage compensation utilizing roX1 RNA,
while the other half lacked dosage compensation (Figure 3A and
personal communication Art Alekseyenko). The X chromosomes
Author Summary
In fruit flies, the male undergoes dosage compensation to
increase the transcriptional output of its single X
chromosome to match that of the females’ two copies. A
large ribonucleoprotein complex that consists of two large
noncoding RNA, roX1 and roX2, and at least five MSL (male
specific lethal) chromatin-modifying proteins is responsi-
ble. We were surprised to find that transcription of new
roX1 RNA failed in the absence of pre-existing roX RNA.
When we introduced either roX2 or the truncated but
functional version of roX1, expression of endogenous wild-
type roX1 gene was restored. We propose that this
mechanism is essential for ensuring sustained dosage
compensation in males and perhaps also for bursts of new
MSL complex at each cell cycle. Thousands of large
noncoding RNAs have recently been discovered in
vertebrates, many of which are associated with chromatin
remodeling enzymes. We postulate that some of these will
face similar regulatory and functional demands as the roX
RNAs and may have evolved comparable strategies to
control their production.
Autoregulation of a Noncoding RNA Gene
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similar to the situation found in roX1 roX2 double mutant animals
[17]. Males also exhibited a similar mosaic phenotype when their
only source of MSL2 was the H83M2 transgene demonstrating
that failed dosage compensation cannot be due to SXL or some
other female factor (Figure 3B). It is unclear how two adjacent cells
that are genetically identical containing a full set of MSL subunits
adopt opposite dosage compensation fates. However, this
fortuitous observation allowed us to test whether failure to activate
the endogenous roX1 gene might explain lack of dosage
compensation in some cells.
In order to test whether pre-existing roX1 RNA is necessary to
drive continued transcription of the roX1 gene, we used a 1.2 kb
roX1 minigene, H83roX1-D39, that is able to form partially active
MSL complexes (Figure 3C) [13]. We designed a probe that
recognizes only the internal sequence of the endogenous roX1
RNA missing from H83roX1-D39. In this way, we could selectively
visualize the expression of only the endogenous roX1 RNA in
Figure 2. Late induction of roX1 expression requires roX2 RNA. In nuclei where dosage compensation was successfully turned on after late
msl2 induction, extensive roX2 was observed painting the entire X chromosome. (A) However, only 1% of the chromosomes showed extensive roX1
painting. 34% and 59% of chromosomes showed roX1 expression confined to several Mbp around (B) or just at the endogenous roX1 locus (C),
respectively. The remaining chromosomes (6%) had no roX1 expression despite the presence of roX2 (data not shown). roX1 and roX2 were detected
by biotin (green, A–C) and digoxigenin (red, A9–C9) labeled antisense riboprobes, respectively. The merged figure is shown in A0–C0. White arrows
denote the endogenous roX1 locus at band 3F.
doi:10.1371/journal.pgen.1002564.g002
Figure 1. MSL proteins alone cannot drive roX1 expression late in development. A) 4 day old larvae were heatshocked to induce expression
of Flp, resulting in the removal of the blocking sequence from GAL4 and subsequent expression of both MSL2 and GFP. MSL2 is expected to initiate
roX transcription and MSL complex assembly. (B) GFP+ clones mark imaginal disc cells that have successfully removed the blocking sequences from
GAL4 (B9–B0). Induction of MSL2 results in punctate subnuclear foci in imaginal disc cells. (C) MSL2 immunostaining of polytene chromosome shows
late MSL2 paints the entire X chromosome. (D) Whole salivary gland showing GFP induced in some cells. (E–E9) roX1 FISH of whole mount of similar
GFP+ salivary glands or (F) polytene squashes shows successful induction of roX1 expression in a subset of cells. (G) roX1 FISH of wildtype males (H)
The same experiment was repeated in roX1
+roX2
2 larvae. However, in the absence of roX2, MSL2 fails to drive roX1 expression. (I) Despite the
presence of GFP+ (late MSL2 expressing) cells, MSL2 is not detectable over the X in (I9–I0) imaginal disc cells or (J) polytene chromosomes. (K) Whole
salivary gland showing successful GFP expression in roX1
+roX2
2 larvae. (L–L9) Expression of roX1 is never observed painting the X or as nascent
transcripts at band 3F in separately processed GFP+ glands or on (M) polytene squashes.
doi:10.1371/journal.pgen.1002564.g001
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(Figure 3D, 3H and Figure S1C). The roX2; H83M2 males (roX1
+
roX2
2/Y; msl2
2; H83M2/+) displayed the same mosaic roX1
pattern (Figure 3F) typically seen in polytene squashes (Figure 3A
and 3B). When we introduced H83roX1-D39 into these roX2
H83M2 males, the expression of full-length roX1 RNA made from
the endogenous locus was restored to all cells (Figure 3G and
Figure S1B, lane 3). In addition, while the distribution of roX1
RNA was often limited to a single band or several Mbp around 3F
in nuclei from the mosaic H83M2 males (Figure S1E–S1F), the
endogenous, full-length roX1 RNA coated the entire length of the
X chromosome in nearly all cells when the constitutively expressed
H83roX1-D39 transgene was also present, (Figure S1G). The
H83roX1-D39 transgene was ineffective in H83M2 females (Figure
S1B, lane 4), perhaps because females have two X chromosomes,
depressed MSL1 expression [36] and so require more stimulatory
activity than H83roX1-D39 can supply.
We conclude that the unexpected mosaic pattern found in roX2
H83M2 animals results from a failure of the wild type roX1 gene to
respond to MSL proteins. Providing a constitutive source of roX1
RNA is sufficient to reliably drive transcription of the endogenous
wild type roX1 gene. Taken together, these results support an
autoregulatory model where new transcription of the wild type
roX1 gene requires pre-existing RNA, either roX1 or roX2,i n
addition to MSL proteins. We postulate that the early MSL-
independent burst of roX1 RNA made at blastoderm normally
assembles the first MSL complexes needed to set up the future
maintenance of roX1 transcription in adult males.
Figure 3. roX1 RNA is needed to sustain endogenous roX1 transcription in males. X chromosomes from neighboring cells display a mosaic
pattern in which the MSL complex either succeeded (arrowhead) or failed (arrow) to paint the X from roX2; msl2; H83M2 female (A) and male (B)
salivary glands. (C) Endogenous roX1 and H83roX1D39 transcripts (Orange) and antisense riboprobe recognizing only full length roX1 (green). Whole
mount roX1 FISH using the internal probe on salivary glands from (D) wild type male, (E) wild type female, (F) roX1
+ roX2
2/Y; msl2; H83M2 mosaic
male, (G) roX1
+roX2
2/Y; msl2; H83M2 H83-roX1D39/+ male, (H) roX1
2 roX2
2/Y; msl2; H83M2 H83-roX1D39/+ male. The X chromosomes in G are fully
painted in all cells with MSL complex relying upon roX1-D39 RNA (Figure S1D), but the truncated roX1 RNA is not recognized by the internal probe.
doi:10.1371/journal.pgen.1002564.g003
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polytene chromosomes
The mosaic pattern of dosage compensation described above
has been reported before. Certain hypomorphic alleles of Sxl
unreliably initiate sex determination and so contain a mixture of
XXAA cells that either correctly adopt a female fate repressing
dosage compensation, or mistakenly choose a male fate and paint
their X chromosomes with MSL complex [37]. The mechanism
underlying the mosaic pattern of dosage compensation found in
roX2 H83M2 animals studied here must be different, and we set
out to understand its basis.
We first tested if the mosaic pattern was a peculiarity of polytene
cells or a general feature in most tissues of these animals. When we
performed MSL2 immunostaining on diploid imaginal discs,
MSL2 protein decorated a subnuclear domain presumed to be the
X chromosome in all the imaginal disc cells when both roX RNAs
were present in female cells carrying the H83M2 transgene
(Figure 4A). Again, roX1
2 roX2
+ animals also had no trouble
establishing dosage compensation in all the cells (data not shown).
However, when roX2 was deleted, only a fraction of the cells
displayed dosage compensation utilizing roX1 RNA (Figure 4B–
4B0), similar to the spotty pattern observed in salivary glands
(Figure 3A, 3B and 3F). When both roX genes were deleted, no
MSL2 staining was detected (Figure 4C–4C0). We had expected
that removing roX RNA would produce a diffuse nuclear cloud of
MSL2 protein unable to bind to the X chromosome. Either diffuse
MSL2 protein stains too weakly to detect with our antibodies, or
MSL2 protein is unstable without roX RNA. The latter is likely to
be the case since MSL2 was previously shown to be unstable when
not packaged into MSL complexes [29]. To directly test this
interpretation, we incubated the imaginal discs and salivary glands
with MG132, a proteasome inhibitor, before performing MSL2
immunostaining. Strong nuclear MSL2 staining reappeared
(Figure 4D–4D0) in the imaginal disc, showing that MSL2 is
synthesized in the absence of roX RNA, but fails to accumulate due
to rapid turnover. MSL2 protein stabilized by MG132 showed a
dramatically different staining pattern covering all polytene
chromosomes, rather than being restricted to the X (Figure S2).
This shows that free MSL2 subunits have a general affinity for all
chromatin in agreement with earlier biochemical work [22].
Apparently flies have evolved a mechanism to efficiently destroy
any MSL2 subunits that fail to assemble into complexes with roX
RNA. A somewhat similar situation was reported for the MSL1
subunit. Massively over expressed MSL1 transiently paints all
chromosome arms but is quickly lost [36].
Our data suggest that many cells lacking roX2 RNA were unable
to carry out dosage compensation because the remaining wild type
roX1 gene failed to switch on. If true, this should affect the viability
Figure 4. Dosage compensation fails in many diploid cells relying exclusively on roX1 and H83M2. (A–A0) Males and females relying
entirely on H83M2 showed subnuclear MSL2 staining in all wing imaginal disc cells when both roX1 and roX2 RNAs were present. (B–B0) Many cells
lacked dosage compensation if roX1
+ was the only source of roX RNA. (C–C0) MSL2 did not accumulate over the X when both roX1 and roX2 were
absent. (D–D0) Nuclear staining of MSL2 was easily detected in the absence of roX RNA after treatment with MG132, a proteasome inhibitor.
doi:10.1371/journal.pgen.1002564.g004
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by H83M2 is toxic to females (Figure 5A) [30] and toxicity requires
roX RNA (Figure 5B) [17]. We found that roX2 alone was almost
equally toxic to females as when both RNAs were present
(compare Figure 5A–5C). The surviving adults produced very few
eggs and were sterile. However, roX1 alone was much less toxic to
females (Figure 5D) as would be expected if many cells lacked
dosage compensation and thus escaped the toxic effects of MSL2
production. These surviving females were fertile. We conclude that
the mosaic dosage compensation pattern is not limited to polytene
tissues, but instead reflects a widespread failure of MSL2 protein
made by the constitutive H83M2 transgene to activate the
endogenous roX1 gene.
H83M2 does not turn on the expression of roX1 reliably
Males that lack roX2, but are in all other ways wild type, have
normal dosage compensation in all cells utilizing the remaining
wild type roX1 gene [17]. Finding spotty roX1 activation only in
animals relying on H83M2 prompted us to examine why the
transgene did not behave like the endogenous msl2 locus in only
this unusual genetic background. MSL2 made from the endoge-
nous locus must activate roX1 RNA production more effectively
than transgenic MSL2. This was shown by introducing single wild
type allele of endogenous msl2 to roX2; H83M2 males and
observing dosage compensation in all cells (Figure S3G and S3I
lane 5, Figure S4E and S4G lane 5). Next, we turned to the NOPU-
M2 transgene that also escapes SXL repression in females, but
differs from H83M2 by using the endogenous msl2 promoter [21].
NOPU-M2 is not toxic to females because it makes less MSL2
compared to H83M2. However, addition of the NOPU-M2
transgene to roX2 mutant females makes them sensitive to the
toxic effects of H83M2 (Figure 5E). Females carrying both msl2
transgenes also drive activation of roX1 expression in all cells
(Figure S3H and S3I lane 6, Figure S4F and G lane 6). This is
unlikely to be a simple additive effect of two pools of MSL2 protein
since the H83M2 transgene itself was fully capable of driving roX1
expression in 100% of the cells when roX2 was present (Figure
S3C–S3D, and S3I lane 1–2 and Figure S4A–S4B and S4G lane
1–2). We propose that H83M2 differs from the endogenous msl2
gene in some way needed to reliably drive the roX1 autoregulatory
loop.
The mosaic pattern might arise from the H83M2 transgene
suffering from positional effect so MSL2 protein was not made in
some cells. This is not the case since MSL2 expression can be
clearly observed in all cells when both roX RNAs are present
(Figure 4A). A second possibility is that H83M2 initiates expression
too late in embryogenesis to capture the early MSL-independent
roX1 transcripts we postulate are needed to begin the autoregu-
latory loop. We performed both MSL2 immunostaining and roX1
FISH on roX2; msl2; H83M2 embryos from 2 h to 20 h AEL.
These embryos showed H83M2 expression and subnuclear
punctate roX1 accumulation in essentially all cells at early
gastrulation and remained on through at least until 20 hrs AEL
when cuticle formation prevents reliable staining of internal tissues
(Figure S5 and Figure S6). These results suggest that H83M2 does
come on during early embryogenesis and is effective in driving
roX1 transcription during the rapid cell divisions of embryonic
development. However, many cells subsequently lose roX1
transcription, and thus dosage compensation, later during larval
stages.
Cell cycle regulation of msl2 expression
The MSL complex associates with many hundreds of actively
transcribed genes along the male X. We considered the possibility
that like core histone proteins, the MSL complex might need to
abruptly increase its abundance following DNA replication. We set
out to test if the transcription of msl2 might be coupled to S phase.
Figure 5. roX2 mutant females escape the toxic effects of
H83M2. Adult females eclosing each day were counted from a
population of eggs laid on day one. White bars show non-transgenic
females without ectopic MSL2 (except E), and black bars show females
carrying the H83M2 transgene. Each experiment varied the roX
genotype. (A) roX1
+ roX2
+, (B) no roX, (C) roX2
+ only, (D) roX1
+ only,
(E) roX1
+ only. Cumulative viability of H83M2 females is shown as a
percentage of their non-transgenic sisters.
doi:10.1371/journal.pgen.1002564.g005
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growing msl2 transcripts on polytene chromosomes. Most salivary
gland cells have completed their endoreplication cycles at the
wandering larval stage used in all our experiments, but a few cells
are still actively replicating. When males carrying both the wild
type endogenous msl2 gene and the H83M2 transgene were treated
with antisense msl2 riboprobes, all nuclei showed strong hybrid-
ization to a cloud of msl2 RNA over the H83M2 transgene inserted
at 87A (Figure 6A). By contrast, a weaker hybridization signal was
observed over the endogenous msl2 gene at 23F in only about 20%
of the nuclei. Most nuclei lacked detectable msl2 transcripts at the
endogenous locus. We tested whether the H83M2 transgene might
somehow inhibit expression of endogenous msl2 gene by testing
nontransgenic, wild type males. We found that again, only about
20% of male cells actively transcribed msl2 (data not shown). This
shows that while wild type males have abundant MSL2 protein
painting the X chromosome in all cells, few cells are making new
msl2 mRNA.
To test if the sporadic transcription of endogenous msl2 might
coincide with the replication phase of the cell cycle, we briefly
incubated dissected salivary glands in EdU to label newly
replicated DNA, fixed the glands, and processed them for msl2
FISH. We found a strong bias (Fisher’s exact test p,0.0001) for
replicating cells to also be transcribing msl2, but the overlap was
not perfect (Figure 6A). For comparison we also examined histone
H2A transcription, but even outside S phase every nucleus
contained an intense hybridization signal over the endogenous
histone gene cluster at polytene band 39DE (Figure S7). Only a
portion of histone mRNA regulation occurs at transcription
initiation. Most regulation is posttranscriptional [38,39].
To directly test whether the sporadic msl2 transcription pattern
is associated with S phase, we treated our salivary glands with
1 mM of hydroxyurea (HU) to inhibit replication. EdU incorpo-
ration was completely blocked (Figure 6B9) but more significantly,
transcripts were specifically lost only from the endogenous msl2
locus at 23F while msl2 transcripts made from the H83M2
transgene at 87A remained strong (Figure 6B, 6B0). Likewise, HU
treatment had no effect on bulk nascent transcripts as shown by
strong incorporation of BrUTP on all chromosome arms
(Figure 6C). These results show that msl2 transcription normally
occurs around S phase and is blocked by replication inhibitors. By
contrast, H83M2 does not show any cell cycle regulation. This
difference might impact roX1 expression.
To test whether the replication associated msl2 transcription
might be limited to only polytene cells with unusual cell cycles, we
examined mitotically dividing diploid S2 cell in culture. Actively
growing S2 cells were sorted into G1, S, and G2 (Figure 6G) via
FACS (Fluorescence Activated Cell Sorting). RNA from these
populations was assayed for msl2, histone H2A, and PKA transcripts
by qPCR. As previously reported [38], histone RNA accumulates
during S phase but is low in G1 and G2 (Figure 6E). Importantly,
msl2 transcripts are most abundant during S while lowest during
G2 phase (Figure 6F). These results show that msl2 RNA
accumulation and synthesis normally occur predominantly in S
phase, but the H83M2 transgene lacks this coordination with
replication.
We attempted to determine whether roX1 transcription was also
linked to S phase as might be expected, but were unsuccessful. We
used both BrUTP and EU (Ethynyl Uridine) to label all new
transcripts followed by a cold chase. We anticipated that the bulk
of mRNA would leave the nucleus while newly labeled roX1 RNA
remained behind on the X. However, we were unable to detect
any labeled RNA localized on the male X after chase (data not
shown). We do not know if the signal was too weak to detect, or if
the substitutions at the 5 position of uridine interferes with the
function of RNA [40], leading to problems in roX1 RNA folding,
stability, MSL protein assembly, and/or targeting to the X.
Discussion
Previous studies of roX1 transcriptional control argued that
either MSL2 alone or with a full set of MSL proteins was sufficient
to drive male-specific expression [31–33]. Here, we present
evidence that the expression of roX1 gene is instead controlled
through an autoregulatory loop. Pre-existing roX RNA, presum-
ably in mature MSL complex, is required to drive new
transcription. The reason we reached a different conclusion is
largely attributed to removing the functionally redundant roX2 in
most of our experiments and assaying transcription only from the
wild type roX1 locus at its normal location on the X. The pathway
we describe shares some elements with the negative regulatory
loop between TFIIIA binding 5S rDNA to drive transcription or
5S rRNA for storage during Xenopus oogenesis [41].
A model for autoregulation of roX1
Figure 7 shows a model for how such an autoregulatory loop
might operate. Because roX RNA is not maternally deposited into
embryos, one problem is how male embryos could build their first
MSL complex needed to initiate the cycle. Meller has shown that
roX1 transcription switches on in both sexes around blastoderm, just
as general zygotic transcription begins [15,16]. This suggests that an
embryonicroX1 promoterisactivewithout MSLcomplex and could
supply the first roX1 RNA molecules to males, but these RNAs are
eventually degraded in females. Early RNA assembles with MSL
proteins and then drive roX1 transcription from the known male-
specific MSL-dependent promoters, setting up a positive autoreg-
ulatoryloop necessaryforthefuturemaintenanceofroX1 expression
in males. In our experiments, we showed that roX2 RNA or
truncated roX1 RNA can also initiate endogenous roX1 expression
late in development after the early roX1 transcripts are gone.
This model requires that male embryos preferentially sequester
newly assembled MSL complex at the roX1 gene to drive sustained
transcription instead of allowing it to diffuse away to the vastly
larger pool of ordinary X linked genes that must be dosage
compensated. Only after roX1 transcription is successfully
upregulated can MSL complexes be released to the target genes
along the X chromosome. Such behavior has been previously
documented in cells containing abundant free MSL subunits and
low levels of roX1 transcription, exactly the conditions we believe
occur as young male embryos initiate dosage compensation [13].
Examining cells shortly after MSL2 first turned on roX1
transcription showed the earliest roX1 transcripts remained near
the site of synthesis (Figure 2B and 2C) consistent with the idea
that newly formed MSL complexes preferentially act on the roX1
gene. At later times, such as seen in H83roX1-D39 animals that
have had five days to drive endogenous roX1 expression, every cell
painted the entire X with roX1 RNA (Figure 3G). While massive
local cis spreading of the MSL complex has been reported for roX1
and roX2 transgenes inserted into autosomes [13,18,42], the
physiological relevance of this is not widely accepted
[25,26,43,44]. Here we instead report striking local cis spreading
of newly made MSL complex from the wild type roX1 gene in its
normal X chromosome environment (Figure S1E–S1F). Our data
agree well with previous reports of local MSL spreading along the
X [19] and support a role for cis spreading in the normal process
of dosage compensation.
We have not directly determined what region of the roX1 gene is
necessary for autoregulation. However, a strong candidate is the
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PLoS Genetics | www.plosgenetics.org 8 March 2012 | Volume 8 | Issue 3 | e1002564Figure 6. Transcription of msl2 is correlated with cell cycle. Nascent msl2 transcripts were detected with antisense FISH riboprobe in salivary
glands. (A) Transgenic H83M2 expression (bright signal indicated by red triangle) was observed at the 87A insertion site in all nuclei. Hybridization to
the endogenous msl2 locus at 23F (faint band indicated by red arrow in inset) was seen in only a minority of nuclei. Because of the difference in signal
intensities between the two msl2 loci, the inset is enhanced to show the weaker signal. (A9) EdU incorporation shows that this is one of the few nuclei
undergoing endoreplication. (B) After treatment with 1 mM of HU (hydroxyurea), no cell transcribed the endogenous msl2 gene (red arrow) but the
transcription of H83M2 continued (red triangle). (B9) HU blocked EdU incorporation from any cell. (C) Simultaneous treatment of salivary glands with
HU, BrUTP, and EdU showed that blocking replication did not inhibit bulk transcription in these cells. (D) Many nuclei without (left table, N=162) or
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about 1.5 kb downstream of the adult roX1 promoters. The DHS
is sufficient to recruit the MSL complex to ectopic sites when
moved to the autosomes in a sequence specific manner [45,46].
While partial complexes lacking MOF or MSL3 remain bound to
the DHS, incomplete complexes lacking either roX RNA or the
MLE RNA helicase postulated to fold roX RNA bind the DHS
poorly [45,46]. This element stimulates roX1 transcription when
MSL complex is bound and represses basal transcription when
MSL complex is absent. Also, deleting the DHS greatly reduces
transcription of roX1 transgenes [33]. Together, these findings
support a model where transcription from the roX1 gene requires
pre-existing roX RNA within MSL complexes bound to the
internal DHS enhancer. However, this view is likely an
oversimplification because very large internal deletions such as
roX1
ex7B, comparable to our H83roX1-D39 transgene (Figure 3A),
remain transcriptionally active despite the loss of the DHS
enhancer [32,47].
Cell cycle regulation
Translation of msl2 mRNA is normally subject to elaborate
controls acting through the 59 and 39 UTRs [48–52]. Little
attention has been given to its transcription control, although
recently anti-MSL2 antibodies were found to precipitate msl2
mRNA [53]. We found that msl2 transcription is associated with
replication, and this is likely important for its normal control.
Without MSL2 protein, naked roX1 RNA is rapidly destroyed
[11]. Here we found the converse; cells rapidly clear any MSL2
protein not bound to roX RNA. When free MSL2 subunits are
artificially stabilized with proteosome inhibitors, they coat all the
chromosomes indiscriminately. This implies that the synthesis of
MSL2 and roX RNAs are closely coordinated so each component
stabilizes the other ensuring that only correctly targeted molecules
survive. Although MSL2 lacks known RNA binding motifs,
previous work of others is consistent with an intimate interaction
between MSL2 and roX RNA [31]. We suspect the loss of
replication-coupled transcription may contribute to the failure of
dosage compensation in some cells relying exclusively on H83M2
for MSL2 protein and roX1 for roX RNA. This defect is corrected
when both roX1 and MSL2 are coordinately made from the same
hsp83 promoter (Figure 3G). Cells in mosaic animals lose dosage
compensation sometime between the end of embryogenesis and
third instar larvae. Many tissues undergo significant changes in cell
cycle near the end of embryogenesis, particularly the introduction
of G1 [54], and we suspect this shift contributes to loss of dosage
compensation in our mosaic animals. If MSL complex should ever
drop below the level needed to sustain the autoregulatory roX1
loop, it could never recover regardless of later MSL2 production.
The details remain unclear because H83M2 is vigorously
transcribed at the developmental times we examined, including
S phase. We do not know whether the regulatory msl2 UTR
sequences removed from H83M2 disrupt additional posttranscrip-
tional controls that might promote efficient translation during
replication.
A second issue is that the X is painted with MSL complex
throughout the cell cycle. This might drive continuous rather than
cyclic roX1 synthesis. While we were unable to directly determine if
roX1 transcription is cell cycle regulated, we note that the
replication machinery components ORC2 and MCM are bound
specifically to the roX1 DHS enhancer only in male cells (Figure
S8A). The significance of this is not known, but it is tempting to
speculate that components of the pre-initiation complex bound to
DHS compete with MSL complex thus inhibiting roX1 transcrip-
tion in G1. Firing of the replication origins removes ORC2 and
MCM possibly allowing MSL complex access to the DHS and so
switch on transcription shortly after the onset of S phase. The
replication machinery is commonly found near the promoters of
many genes [55], including msl2 (Figure S8B), so further
experiments will be needed to determine if such binding actually
plays any regulatory role here.
Figure 7. Autoregulation model. The earliest roX1 transcripts (red) made at blastoderm originate from an uncharacterized MSL-independent
promoter. This RNA may assemble with MSL protein subunits to produce the first functional MSL complexes needed to bind the internal DHS
enhancer that drives sustained transcription (blue) from the male-specific promoters. When present, roX2 RNA can also drive roX1 transcription.
Components of the replication pre-initiation complex also bind the DHS sequence in male cells (Figure S8A). The msl2 transcripts are made
predominantly during replication and new MSL2 protein is needed to assemble and stabilize newly made roX1 RNA.
doi:10.1371/journal.pgen.1002564.g007
with (right table, N=170) HU treatment were scored for expression of endogenous msl2 and EdU incorporation. Nascent transcripts were detected at
the H83M2 transgene in 100% of the nuclei (data not represented in the table). After sorting growing S2 cells into their respective phase of cell cycle
via FACS, qPCR was done to quantify H2A (E) and msl2 (F) transcripts levels normalized to PKA. (G) The FACS profile of unsorted (U) and sorted S2 cells
(G1, S and G2 cell cycle). The sorted cells have a slightly higher content of Vybrant Violet-A dye because the cells are collected into tubes containing
Vybrant Violet-A. The Y-axes are drawn on different scales.
doi:10.1371/journal.pgen.1002564.g006
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While we did not specifically address transcriptional control of
roX2, it must differ from roX1 in several important ways. Meller has
previously shown that roX2 transcription lags roX1 by a few hours
during early embryonic development and is always limited to
males [16]. Here we found that roX2 transcription differs by not
requiring pre-existing roX RNA and can be switched on several
days later during larval development simply by ectopically
expressing MSL2. MSL2 protein made by the constitutive
H83M2 transgene only sporadically activates roX1, but robustly
drives roX2. The roX2 gene also carries a DHS enhancer similar to
that found in roX1 [45], but if it plays a comparable role in roX2
regulation, it presumably would not require complete MSL
complex. The region near the proline rich domain towards the
C-terminus of MSL2 is essential for this regulation [31].
Parallels between roX1 and Sxl
The roX1 autoregulation loop described above shares parallels to
the SXL autoregulatory loop controlling all aspects of sex
determination and dosage compensation in Drosophila. X:A counting
elements act upon an early establishment Sxl promoter to make SXL
in early female embryos. These first SXL proteins stimulate
productive splicing of Sxl mRNAs transcribed from a distinct
maintenance promoter ensuring further SXL production [56].
MSL1, MSL3, MOF, and MLE are unable to package early roX1
RNAmadefromtheembryonicpromoterinfemaleembryostoform
a fully functional mature MSL complex. To do that, MSL2 protein
made only in males is required. We suspect these earliest MSL
complexes sustain roX1 transcription as embryos switch to the MSL-
dependent promoters. Recently a new role for MSL2 in females has
been described during the brief window when Sxl autoregulation is
established [57]. Perhaps females also fleetingly utilize the early burst
of roX1 before abundant SXL represses msl2 translation.
Thousands of large noncoding RNAs have recently been
discovered in vertebrates [2,58], many of which are associated
with chromatin remodeling enzymes [1,59–61]. It is likely that
some of these will face similar regulatory and functional demands
as the roX RNAs and may have evolved comparable strategies to
control their production. For instance, the short RepA sequence at
the 59 end of mammalian Xist RNA may influence production of
full length transcripts [59].
Materials and Methods
Drosophila stocks
Larvae and flies were raised on standard cornmeal-yeast-agar-
molasses medium containing propanoic acid at 25uC. In all
experiments the roX1 mutation is roX1
ex6 and the roX2 allele is Df
(1) roX2
52 [17]. The [w
+ 4D4.3] transgene supplies essential
adjacent genes lost in the roX2 deletion.
The transgenic flies used have been previously described as
follows:[w
+H83M2-6I][3 0 ] ,[w
+NOPU-M2][ 21],and[w
+H83roX1-
D39][ 13]. The H83M2 transgene was recombined with [P{SUPor-
P}KG02776] which contains y
+ as a marker so larvae of the correct
genotype could be recognized by mouth hook color (Flybase). The
P{GAL4-Act5C(FRT.CD2).P}, P{UAS-GFP.S65T} and MKRS-hsFLP
transgenic fly stocks were provided by Graeme Mardon.
The UASp-MSL2 transgene was made by digesting the H83M2
transgene with EcoRI and subcloning the MSL2 ORF into the
pUAS-P2 plamid vector (a gift from Pernille Rørth).
Heatshock
The female larvae for the flp-out experiment were kept at 25uC
and heatshocked at 37uC for 1 hr each at day 4 and 5 AEL. Their
salivary glands were then dissected on day 6 AEL, fixed and
immunostained as described below.
The full genotypes of the larvae heatshocked in Figure 1 are as
follows:
B-F) yw ;[ w
+ y
+Act-FRT-CDC2-FRT-Gal4] [w
+UAS-GFP] +/+
+ [w
+UASp-MSL2]; MRKS [Hs-Flp]/+
H-L) y w roX2
52 [w
+4D4.3]; [w
+ y
+Act-FRT-CDC2-FRT-Gal4]
[w
+UAS-GFP] +/++[w
+UASp-MSL2]; MRKS [Hs-flp]/+
The full genotypes of the larvae in Figure 2 are identical to
Figure 1H–1L.
The full genotypes of the larvae in Figure 3 are as follows:
A) y w roX2
52 [w
+4D4.3]; msl2; [w
+H83-M2] [w
+y
+P{SUPor-
P}KG02776]/++
B) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+y
+P{SUPor-
P}KG02776]/++
D) y w/Y
E) yw
F) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-
P}KG02776]/++
G) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+H83-
roX1D39] [w
+y
+ P{SUPor-P}KG02776]/+++
H) y w roX1
ex6roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+H83-
roX1D39] [w
+y
+ P{SUPor-P}KG02776]/+++
The full genotypes of the larvae in Figure 4 are as follows:
A-A0) y w; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-P}KG02776]
B-B0) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+y
+P{SU-
Por-P}KG02776]/++
C-C0) y w roX1
ex6 roX2
52 [w
+4D4.3]/Y; msl2/+; [w
+H83-M2]
[w
+y
+P{SUPor-P}KG02776]/++
D-D0) Same as C
The full genotypes of the parents in the crosses for Figure 5A–
5E are as follows:
A) y w/Y; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-P}KG02776]/++
X y w; msl2
B) y w roX1
ex6/Y; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-
P}KG02776]/++X y w roX1
ex6; msl2
C) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-
P}KG02776]/++X y w roX2
52 [w
+4D4.3]; msl2
D) y w roX1
ex6 roX2
52 [w
+4D4.3]/Y; msl2/+; [w
+H83-M2] [w
+y
+
P{SUPor-P}KG02776] +/++[w
+GMroX1
+] X y w roX1
ex6 roX2
52
[w
+4D4.3]
E) y w roX2
52 [w
+4D4.3]/Y; msl2; [w
+H83-M2] [w
+y
+ P{SUPor-
P}KG02776]/++X y w roX2
52 [w
+4D4.3]; [w
+NOPU-M2]
Immunohistochemistry and in situ hybridization
Immunostaining and in situ hybridization on third instar salivary
glands was performed as described in [11] except for the following
modification. The slides were treated with proteinase K (20 mg/ml
in PBT) for 3 min. Each slide was hybridized with 5 ng of roX1,
msl2 or H2A biotin-labeled single-stranded antisense riboprobes
using the T7 high yield Transcription kit #K0441 (Fermentas).
Fluorescent development was done as instructed by the Tyramide
Signal Amplification (TSA) kit (NEL700A) (PerkinElmer) with SA-
FITC (NEL720) (PerkinElmer) or SA-Texas Red (NEL 721)
(PerkinElmer). For double ISH, we labeled the second antisense
riboprobes with digoxygenin. Before adding the anti-digoxygenin-
HRP conjugate, the first horseradish peroxidase conjugate was
quenched in 3% H2O2 for 30 mins. The second color is then
developed using Tyramide-Alexa488 (T20922) (Invitrogen). To
inhibit MSL2 degradation, we incubate imaginal discs and salivary
glands with 10 mM of MG132 (474791) (Calbiochem) dissolved in
Schneider Culture Media for 3 hours before proceeding with
immunostaining.
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To block replication, salivary glands from 3
rd instar larvae were
first incubated in 1 mM HU for 1 h. If not, they were simply
incubated in S2 cell culture media (see below). After which, the
glands were transferred and incubated in EdU for 15 minutes
followed immediately by fixation. The detection was then
performed as instructed by the Click-iT EdU imaging kit
#C10337 (Invitrogen). Both HU and EdU were dissolved in S2
cell culture media before use.
Co-labeling replicating DNA and nascent transcripts via
EdU and BrUTP respectively
Salivary glands were initially treated the same way as described
above. However, after HU treatment, the glands were incubated
in a BrUTP/DOTAP/EdU mixture instead for 15 mins. The
BrUTP/DOTAP mixture was previously described to allow
efficient nucleotide triphosphate uptake by the cell to label nascent
transcripts [62]. EdU detection was performed as described above.
Rat Anti-BrdU monoclonal antibodies #NB500-169 (Novus
Biological) and Goat anti-rat Alexa 594 #A11007 (Invitrogen)
were then used as primary and secondary antibodies respectively,
to detect BrUTP.
Cell culture and FACS
Schneider 2 (S2) cells were cultured in 15-cm plates at a density
of 1610
6 cells/ml in Schneider’s Media #11720034 (Invitrogen)
supplemented with 10% FCS and penicillin/streptomycin. After
reaching a density of 5610
6 cells/ml, the cells were re-suspended
in new culture media containing 5 mM of Vybrant Dye Cycle
Violet #V35003 (Invitrogen) to stain the DNA. The cells were
then sorted into their respective phase of cell cycle via FACSAria
II (BD Biosciences) at the Cytometry and Cell Sorting Facility
located in Baylor College of Medicine.
Real-time PCR
Total RNA was extracted from cells using TrizolH reagent
15596-018 (Invitrogen) as per the manufacturer’s protocol. cDNA
was synthesized from 0.5–1 mg of total RNA using random
hexamers and MMLV Reverse transcriptase #M1701 (Promega)
as per manufacturer’s protocol. The cDNA was purified using
MinElute PCR kit #28004 (Qiagen).
Real-time PCR was performed using an Applied Biosystems
7300 Sequence Detection system. The 25 ml PCR included 1 ml
cDNA, 16SYBRH Green PCR Master Mix #4309155 (Applied
Biosystems) and 1 ml of gene specifc primers. The reactions were
incubated in a 96-well optical plate at 95uC for 10 min, followed
by 40 cycles of 95uC for 15 s and 60u for 10 min. The Ct data was
determinate using default threshold settings. The threshold cycle
(Ct) is defined as the fractional cycle number at which the
fluorescence passes the fixed threshold. PKA is used as an
endogenous standard for normalization of histone H2A and msl2.
The primers used for qPCR are: H2A forward TGGACGTG-
GAAAAGGTGGCA; H2A reverse ACGGCAGCTAGG-
TAAACTGGAG; MSL2 forward GGCGAGTACCAGGGCTT-
CAATATC; MSL2 Reverse TGCTGCAGCTGGACACG-
AATAG; PKA forward – AGCCGCACTCGCGCTTCTAC
and PKA reverse - AGCCGGAGAATCTGCTGATTG.
Supporting Information
Figure S1 The [H83-roX1D39] transgene turns on endogenous
roX1 in males. (A) roX1 transcripts (Orange) and antisense probes
(green). (B) Quantification of roX1 hybridization over polytene X
chromosomes: entire X (black), only distal X (gray, example E), a
single band at the roX1 locus (hatched, example F red arrowhead),
or no staining (white). N=nuclei counted. The [H83-D39roX1]
transgene does not have an effect on females. (C) The internal
probe does not hybridize to D39roX1 RNA, (D) but the roX1D39
probe does. White line delineates the X chromosome. (E) Males
display a diverse pattern of roX painting, ranging from local
spreading from the roX1 locus to (F) just a single band (indicated by
the red arrow). (G) D39roX1 RNA (not visualized) helps [H83-M2]
strongly activate endogenous roX1 (detected with internal probe) in
almost all cells (two nuclei shown) (H) Similar roX1 staining was
found in all squashed imaginal disc cells.
(PDF)
Figure S2 MSL immunostaining reveals that MSL2 binds
indiscriminately to all the chromosomes in the absence of any
roX RNA. (A) In the presence of roX RNA, MSL2 binds and
paints the X chromosome only. (B) In the absence of roX RNA, the
MSL proteins form incomplete complexes and binds to all the
chromosomes, albeit poorly. (C) After treatment with MG132, a
proteasome inhibitor, strong MSL2 binding can now be observed
to occur throughout the nucleus. roX1
2 roX2
2 males are sick and
do not survive till adulthood. However, sick and rare 3
rd instar
larvae can be obtained for salivary squashes although the
chromosomes have extremely poor morphology and easily
shattered during squashes. (D) The same experiment was repeated
in whole mount salivary glands and MSL2 can be seen
concentrated on the X chromosome. (E) At low resolution,
MSL2 staining becomes undetectable in the absence of roX RNA
(compared to B). (F) MSL2 can be seen binding to the entire
nucleus when degradation is being inhibited.
(PDF)
Figure S3 MSL immunostaining of polytene chromosomes in
[H83-M2] expressing larvae reveals mosaic establishment in DC.
MSL immunostaining and DAPI is represented by red and blue
respectively. (A) The MSL complex is bound along the male single
X chromosome at hundreds of bands. (B) Due to the lack of
MSL2, female do not have MSL binding to the X chromosome.
(C–D) Painting of the X can be restored by the [H83-M2]
transgene in msl2 mutant animals if both roX1 and roX2 are
present. (E) The MSL complex fails to paint the entire X
chromosome in males if roX2 is deleted. This cis-spreading
phenomenon around the roX1 locus (indicated by red arrow) is
similar to the autosomal spreading of roX1 transgene observed
under low transcription rate (9). (F) In females, the X chromosome
is either painted (arrowhead) or not painted (arrow). See Figure 1I
for quantification. (G–H) Normal painting of the X is re-
established when an endogenous copy of msl2 is restored. In
females, this is achieved by co-expressing the [NOPU-M2]
transgene. (I) The fraction of polytene nuclei displaying complete,
partial, or no X MSL1 painting is shown. N=nuclei scored.
Genotypes: (1–2) roX1
+roX2
+;msl2;[H83-M2]/+, (3–4) roX1
+-
roX2
2;msl2;[H83-M2]/+, (5) roX1
+roX2
2/Y;msl2/+;[H83-M2]/+,
(6) roX1
+roX2
2;msl2/+;[NOPU-M2] [H83-M2]/+.
(PDF)
Figure S4 MSL2 immunostaining of imaginal disc cells in [H83-
M2] expressing larvae reveals mosaic establishment of DC. (A–B)
Painting in all nuclei is observed in animals relying upon the [H83-
M2] transgene if both roX1 and roX2 are present. (C–D) Mosaic
painting of the X chromosome is observed in both males and
females when roX2 is deleted. White arrows indicated unpainted
nucleus. (E–F) Normal painting of the X is re-established when an
endogenous copy of msl2 is restored. In females, this is achieved by
co-expressing the [NOPU-M2] transgene. (G) Cells with (black) and
without (white) obvious subnuclear domain MSL2 staining taken
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counted. Genotypes: (1–2) roX1
+roX2
+;msl2;[H83-M2]/+, (3–4)
roX1
+roX2
2;msl2;[H83-M2]/+, (5) roX1
+roX2
2/Y;msl2/+;[H83-
M2]/+ male, (6) roX1
+roX2
2;msl2/+; [NOPU-M2][H83-M2]/+
female.
(PDF)
Figure S5 MSL2 immunostaining of embryos reveals that 100%
of the cells expressed [H83-MSL2]. (A–A0) A wildtype embryo at
the end of germband extension showing endogenous MSL2
expression detected in 100% of the cells (B–B0)AroX2
2; msl2;
[H83M2] embryos, expected to display a mosaic pattern of dosage
compensation in imaginal discs and salivary glands by 3
rd instar,
shows no signs of mosaicism during early embryogenesis.
(PDF)
Figure S6 roX1 in situ hybridization of embryos reveals that
100% of the cells successfully establish dosage compensation. (A–
A0) A wildtype embryo at about 20 hr AEL, has roX1 expression
detected in 100% of the cells (B–B0) A similarly stage roX2
2; msl2;
[H83M2] embryos displaying no signs of mosaicism.
(PDF)
Figure S7 Histones transcripts not a good marker of S Phase.
(A–A0) Nascent H2A (red arrow) and msl2 transcripts (red
arrowhead) can be visualized at cytolocation 23F and 39
respectively via double ISH of polytene chromosomes with anti-
sense msl2 and H2A RNA probes. (B) Although it is well
documented that the transcription rate of histones decreases by
5 folds upon Hydroxurea treatment [38], it is hard to quantified
using the TSA technique for ISH. (B9–B0) On the other hand, msl2
transcripts have completely disappeared upon HU treatment.
(PDF)
Figure S8 Components of the DNA replication preinitiation
complex bind transcriptional control regions within both roX1 and
msl2 genes. (A) Both MCM and ORC2 bind the DHS control
region within roX1 only in male cells. (B) Preinitiation complex is
located near the promoters of many genes including msl2. Binding
data shown for S2 cells. Screen captures of ChIP-seq data of the
MacAlpine lab deposited in FlyBase Modencode. Y-axes not the
same for different profiles.
(PDF)
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